dockets: FDA-2026-P-5017
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2026-P-5017 | FDA | Request that the FDA determine whether the Reference Listed Drug (RLD) VELTASSA (PATIROMER SORBITEX CALCIUM) Oral Powder, Eq 25.2 gm Base/Packet; under New Drug Application (NDA) 205739 held by VIFOR PHARMA INC, was voluntarily withdrawn from commercial distribution, or withdrawn from sale for safety or efficacy reasons | Nonrulemaking | 2026-05-07T19:44:54Z | 0b000064b92c7bf5 |
Links from other tables
- 3 rows from docket_id in documents